Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 101

1.

Changing landscape of public health and medical education curriculum.

Ofori-Adjei D.

Ghana Med J. 2018 Sep;52(3):115. doi: 10.4314/gmj.v52i3.1. No abstract available.

2.

Estimated glomerular filtration rate predicts incident stroke among Ghanaians with diabetes and hypertension.

Sarfo FS, Mobula LM, Sarfo-Kantanka O, Adamu S, Plange-Rhule J, Ansong D, Gyamfi RA, Duah J, Abraham B, Ofori-Adjei D.

J Neurol Sci. 2019 Jan 15;396:140-147. doi: 10.1016/j.jns.2018.11.017. Epub 2018 Nov 15.

3.

Incident stroke among Ghanaians with hypertension and diabetes: A multicenter, prospective cohort study.

Sarfo FS, Mobula LM, Plange-Rhule J, Ansong D, Ofori-Adjei D.

J Neurol Sci. 2018 Dec 15;395:17-24. doi: 10.1016/j.jns.2018.09.018. Epub 2018 Sep 13.

4.

A multi-center prospective cohort study to evaluate the effect of differential pricing and health systems strengthening on access to medicines and management of hypertension and diabetes in Ghana: A study protocol.

Mobula LM, Sarfo S, Arthur L, Burnham G, Plange-Rhule J, Ansong D, Gavor E, Ofori-Adjei D.

Version 2. Gates Open Res. 2018 May 3 [revised 2018 Jan 1];2:6. doi: 10.12688/gatesopenres.12797.2. eCollection 2018.

5.

Factors associated with uncontrolled blood pressure among Ghanaians: Evidence from a multicenter hospital-based study.

Sarfo FS, Mobula LM, Burnham G, Ansong D, Plange-Rhule J, Sarfo-Kantanka O, Ofori-Adjei D.

PLoS One. 2018 Mar 19;13(3):e0193494. doi: 10.1371/journal.pone.0193494. eCollection 2018.

6.

Towards fair and effective North-South collaboration: realising a programme for demand-driven and locally led research.

Kok MO, Gyapong JO, Wolffers I, Ofori-Adjei D, Ruitenberg EJ.

Health Res Policy Syst. 2017 Nov 13;15(1):96. doi: 10.1186/s12961-017-0251-3.

7.

Which health research gets used and why? An empirical analysis of 30 cases.

Kok MO, Gyapong JO, Wolffers I, Ofori-Adjei D, Ruitenberg J.

Health Res Policy Syst. 2016 May 17;14(1):36. doi: 10.1186/s12961-016-0107-2.

8.

Problems with use of medicines.

Ofori-Adjei D.

Ghana Med J. 2014 Dec;48(4):177. No abstract available.

9.

Of cholera and Ebola virus disease in Ghana.

Ofori-Adjei D, Koram K.

Ghana Med J. 2014 Sep;48(3):120. No abstract available.

10.

Profile of adverse events in patients receiving treatment for malaria in urban Ghana: a cohort-event monitoring study.

Dodoo AN, Fogg C, Nartey ET, Ferreira GL, Adjei GO, Kudzi W, Sulley AM, Kodua A, Ofori-Adjei D.

Drug Saf. 2014 Jun;37(6):433-48. doi: 10.1007/s40264-014-0164-9.

PMID:
24788801
11.

Problems associated with treating visual impairment in resource-poor settings.

Ofori-Adjei D.

Ghana Med J. 2013 Jun;47(2):56. No abstract available.

12.

Aflatoxin exposure in pregnant women in Ghana.

Ofori-Adjei D.

Ghana Med J. 2012 Dec;46(4):178. No abstract available.

13.

Golden jubilee of the Ghana Medical Journal.

Ofori-Adjei D.

Ghana Med J. 2012 Sep;46(3):113. No abstract available.

14.

Pharmacogenetics in Ghana: reviewing the evidence.

Kudzi W, Adjei GO, Ofori-Adjei D, Dodoo AN.

Ghana Med J. 2011 Jun;45(2):73-80.

15.

Buruli ulcer disease.

Ofori-Adjei D.

Ghana Med J. 2011 Mar;45(1):1. No abstract available.

16.

Diagnosis of tuberculosis in ghana: the role of laboratory training.

Addo KK, Yeboah-Manu D, Dan-Dzide M, Owusu-Darko K, Caulley P, Mensah GI, Minamikawa M, Lienhardt C, Bonsu FA, Ofori-Adjei D.

Ghana Med J. 2010 Mar;44(1):31-6.

17.

Aflatoxin-albumin adducts and correlation with decreased serum levels of vitamins A and E in an adult Ghanaian population.

Tang L, Xu L, Afriyie-Gyawu E, Liu W, Wang P, Tang Y, Wang Z, Huebner HJ, Ankrah NA, Ofori-Adjei D, Williams JH, Wang JS, Phillips TD.

Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2009 Jan;26(1):108-18. doi: 10.1080/02652030802308472.

PMID:
19680878
18.

Pregnancy-associated malaria in a rural community of ghana.

Ofori M, Ansah E, Agyepong I, Ofori-Adjei D, Hviid L, Akanmori B.

Ghana Med J. 2009 Mar;43(1):13-8.

19.

European and Developing Countries Clinical Trials Partnership (EDCTP): the path towards a true partnership.

Matee MI, Manyando C, Ndumbe PM, Corrah T, Jaoko WG, Kitua AY, Ambene HP, Ndounga M, Zijenah L, Ofori-Adjei D, Agwale S, Shongwe S, Nyirenda T, Makanga M.

BMC Public Health. 2009 Jul 20;9:249. doi: 10.1186/1471-2458-9-249.

20.

Influence of ethnicity on pharmacogenetic variation in the Ghanaian population.

Yen-Revollo JL, Van Booven DJ, Peters EJ, Hoskins JM, Engen RM, Kannall HD, Ofori-Adjei D, McLeod HL, Marsh S.

Pharmacogenomics J. 2009 Dec;9(6):373-9. doi: 10.1038/tpj.2009.28. Epub 2009 Jun 23.

PMID:
19546880
21.

Investing in health research for endemic diseases.

Ofori-Adjei D.

Ghana Med J. 2008 Sep;42(3):95. No abstract available.

22.

PAH exposure in a Ghanaian population at high risk for aflatoxicosis.

Johnson NM, Afriyie-Gyawu E, Huebner H, Marroquin-Cardona A, Robinson A, Tang L, Xu L, Ankrah NA, Ofori-Adjei D, Jolly PE, Williams JH, Wang JS, Phillips TD.

Sci Total Environ. 2009 Mar 1;407(6):1886-91. doi: 10.1016/j.scitotenv.2008.11.060. Epub 2009 Jan 14.

PMID:
19144392
23.

Pattern of drug utilization for treatment of uncomplicated malaria in urban Ghana following national treatment policy change to artemisinin-combination therapy.

Dodoo AN, Fogg C, Asiimwe A, Nartey ET, Kodua A, Tenkorang O, Ofori-Adjei D.

Malar J. 2009 Jan 5;8:2. doi: 10.1186/1475-2875-8-2.

24.

NovaSil clay does not affect the concentrations of vitamins A and E and nutrient minerals in serum samples from Ghanaians at high risk for aflatoxicosis.

Afriyie-Gyawu E, Wang Z, Ankrah NA, Xu L, Johnson NM, Tang L, Guan H, Huebner HJ, Jolly PE, Ellis WO, Taylor R, Brattin B, Ofori-Adjei D, Williams JH, Wang JS, Phillips TD.

Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2008 Jul;25(7):872-84. doi: 10.1080/02652030701854758.

PMID:
18569006
25.

NovaSil clay intervention in Ghanaians at high risk for aflatoxicosis: II. Reduction in biomarkers of aflatoxin exposure in blood and urine.

Wang P, Afriyie-Gyawu E, Tang Y, Johnson NM, Xu L, Tang L, Huebner HJ, Ankrah NA, Ofori-Adjei D, Ellis W, Jolly PE, Williams JH, Wang JS, Phillips TD.

Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2008 May;25(5):622-34. doi: 10.1080/02652030701598694.

PMID:
18478481
26.

Ghana's Free Delivery Care Policy.

Ofori-Adjei D.

Ghana Med J. 2007 Sep;41(3):94-5. No abstract available.

27.

Diagnosis of Mycobacterium ulcerans infection (Buruli ulcer) at a treatment centre in Ghana: a retrospective analysis of laboratory results of clinically diagnosed cases.

Mensah-Quainoo E, Yeboah-Manu D, Asebi C, Patafuor F, Ofori-Adjei D, Junghanss T, Pluschke G.

Trop Med Int Health. 2008 Feb;13(2):191-8. doi: 10.1111/j.1365-3156.2007.01990.x.

28.

Reducing human exposure to aflatoxin through the use of clay: a review.

Phillips TD, Afriyie-Gyawu E, Williams J, Huebner H, Ankrah NA, Ofori-Adjei D, Jolly P, Johnson N, Taylor J, Marroquin-Cardona A, Xu L, Tang L, Wang JS.

Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2008 Feb;25(2):134-45. doi: 10.1080/02652030701567467. Review.

PMID:
18286403
29.

Mycobacterial species causing pulmonary tuberculosis at the korle bu teaching hospital, accra, ghana.

Addo K, Owusu-Darko K, Yeboah-Manu D, Caulley P, Minamikawa M, Bonsu F, Leinhardt C, Akpedonu P, Ofori-Adjei D.

Ghana Med J. 2007 Jun;41(2):52-7.

30.

Safety of "sachet water" and raw milk.

Ofori-Adjei D.

Ghana Med J. 2007 Jun;41(2):37. No abstract available.

31.

NovaSil clay intervention in Ghanaians at high risk for aflatoxicosis. I. Study design and clinical outcomes.

Afriyie-Gyawu E, Ankrah NA, Huebner HJ, Ofosuhene M, Kumi J, Johnson NM, Tang L, Xu L, Jolly PE, Ellis WO, Ofori-Adjei D, Williams JH, Wang JS, Phillips TD.

Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2008 Jan;25(1):76-87. Epub 2007 Sep 1.

PMID:
17852392
32.

Saying thank you.

Ofori-Adjei D.

Ghana Med J. 2007 Mar;41(1):1. No abstract available.

33.

Surveillance of viral haemorrhagic fevers in ghana: entomological assessment of the risk of transmission in the northern regions.

Appawu M, Dadzie S, Abdul H, Asmah H, Boakye D, Wilson M, Ofori-Adjei D.

Ghana Med J. 2006;40(4):137-41.

34.

Ghana Medical Journal @ www.ghanamedassn.org.

Ofori-Adjei D.

Ghana Med J. 2006 Jun;40(2):38. No abstract available.

35.

Findings from a buruli ulcer mouse model study.

Addo P, Owusu E, Adu-Addai B, Quartey M, Abbas M, Dodoo A, Ofori-Adjei D.

Ghana Med J. 2005 Sep;39(3):86-93.

36.

Special journal issue on neglected diseases.

Ofori-Adjei D.

Ghana Med J. 2005 Mar;39(1):1. No abstract available.

37.

High CD4/CD45RO+ and CD8/CD45RO+ frequencies in children with vaccine-modified measles.

Addae MM, Tetteh JK, Ishiwada N, Komada Y, Yamaguchi S, Ofori-Adjei D, Kamiya H, Akanmori BD.

Pediatr Int. 2006 Oct;48(5):449-53.

PMID:
16970781
38.

Have online international medical journals made local journals obsolete?

Ofori-Adjei D, Antes G, Tharyan P, Slade E, Tamber PS.

PLoS Med. 2006 Aug;3(8):e359. No abstract available.

39.

Situation analysis of TB microscopy centres in Ghana.

Addo KK, Owusu-Darko K, Dan-Dzide M, Yeboah-Manu D, Ablordey A, Caulley P, Minamikawa M, Bonsu F, Lienhardt C, Akpedonu P, Ofori-Adjei D.

Int J Tuberc Lung Dis. 2006 Aug;10(8):870-5.

PMID:
16898371
40.

Improving the laboratory diagnosis of TB in Ghana: the impact of a quality assurance system.

Addo KK, Dan-Dzide M, Yeboah-Manu D, Owusu-Darko K, Caulley P, Minamikawa M, Bonsu F, Lienhardt C, Akpedonu P, Ofori-Adjei D.

Int J Tuberc Lung Dis. 2006 Jul;10(7):812-7.

PMID:
16848346
41.

Normal CD4+ T lymphocyte levels in HIV seronegative individuals in the Manya/Yilo Krobo communities in the Eastern region of Ghana.

Ampofo W, Torpey K, Mukadi YD, Koram K, Nolan K, Amenyah R, Kaitoo E, Antwi P, Ofori-Adjei D, Lamptey P.

Viral Immunol. 2006 Summer;19(2):260-6.

PMID:
16817768
42.

HTLV-1 and other viral sexually transmitted infections in antenatal and gynaecological patients in Ghana.

Apea-Kubi KA, Yamaguchi S, Sakyi B, Ofori-Adjei D.

West Afr J Med. 2006 Jan-Mar;25(1):17-21.

PMID:
16722353
43.

Systemic suppression of interferon-gamma responses in Buruli ulcer patients resolves after surgical excision of the lesions caused by the extracellular pathogen Mycobacterium ulcerans.

Yeboah-Manu D, Peduzzi E, Mensah-Quainoo E, Asante-Poku A, Ofori-Adjei D, Pluschke G, Daubenberger CA.

J Leukoc Biol. 2006 Jun;79(6):1150-6. Epub 2006 Mar 10.

PMID:
16531561
44.

Genetic diversity in Mycobacterium ulcerans isolates from Ghana revealed by a newly identified locus containing a variable number of tandem repeats.

Hilty M, Yeboah-Manu D, Boakye D, Mensah-Quainoo E, Rondini S, Schelling E, Ofori-Adjei D, Portaels F, Zinsstag J, Pluschke G.

J Bacteriol. 2006 Feb;188(4):1462-5.

45.

The middle to 3' end of the HIV-1 vif gene sequence is important for vif biological activity and could be used for antisense oligonucleotide targets.

Barnor JS, Miyano-Kurosaki N, Takaku H, Yamaguchi K, Sakamoto A, Ishikawa K, Yamamoto N, Osei-Kwasi M, Ofori-Adjei D.

Nucleosides Nucleotides Nucleic Acids. 2005;24(10-12):1745-61.

PMID:
16438045
46.

Characteristics of hepatitis B virus in Ghana: full length genome sequences indicate the endemicity of genotype E in West Africa.

Huy TT, Ishikawa K, Ampofo W, Izumi T, Nakajima A, Ansah J, Tetteh JO, Nii-Trebi N, Aidoo S, Ofori-Adjei D, Sata T, Ushijima H, Abe K.

J Med Virol. 2006 Feb;78(2):178-84.

PMID:
16372296
47.

Factors contributing to the development of anaemia in Plasmodium falciparum malaria: what about drug-resistant parasites?

Quashie NB, Akanmori BD, Ofori-Adjei D, Goka BQ, Kurtzhals JA.

J Trop Pediatr. 2006 Aug;52(4):254-9. Epub 2005 Dec 2.

PMID:
16326751
48.

Beta-2 adrenergic receptor genotypes and haplotypes in different ethnic groups.

Maxwell TJ, Ameyaw MM, Pritchard S, Thornton N, Folayan G, Githang'a J, Indalo A, Tariq M, Mobarek A, Evans DA, Ofori-Adjei D, Templeton AR, McLeod HL.

Int J Mol Med. 2005 Oct;16(4):573-80.

PMID:
16142389
49.

Efficacy of the combination rifampin-streptomycin in preventing growth of Mycobacterium ulcerans in early lesions of Buruli ulcer in humans.

Etuaful S, Carbonnelle B, Grosset J, Lucas S, Horsfield C, Phillips R, Evans M, Ofori-Adjei D, Klustse E, Owusu-Boateng J, Amedofu GK, Awuah P, Ampadu E, Amofah G, Asiedu K, Wansbrough-Jones M.

Antimicrob Agents Chemother. 2005 Aug;49(8):3182-6.

50.

HIV-1 proteases from drug-naive West African patients are differentially less susceptible to protease inhibitors.

Kinomoto M, Appiah-Opong R, Brandful JA, Yokoyama M, Nii-Trebi N, Ugly-Kwame E, Sato H, Ofori-Adjei D, Kurata T, Barre-Sinoussi F, Sata T, Tokunaga K.

Clin Infect Dis. 2005 Jul 15;41(2):243-51. Epub 2005 Jun 8.

PMID:
15983923

Supplemental Content

Loading ...
Support Center